Stay updated on AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial
Sign up to get notified when there's something new on the AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial page.

Latest updates to the AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial page
- CheckyesterdayChange DetectedA new revision entry v3.6.5 has been added to the study record history, and the previous revision v3.6.4 has been removed.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA new record-history entry for v3.6.4 is added, and the previous entry v3.6.3 is removed, representing an additional revision to the study record.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedA new revision entry v3.6.3 was added to the study record history, signaling an update to the record documentation. This reflects administrative maintenance rather than changes to core study content.SummaryDifference0.1%

- Check44 days agoChange DetectedThe record history shows a new revision tag v3.6.2 replacing the previous v3.6.0, signaling an update to the study record history.SummaryDifference0.1%

- Check58 days agoChange DetectedThe record history now shows recruitment is closed ('No longer looking for participants'), indicating enrollment has ended. The revision tag has been updated to v3.6.0, replacing the old v3.5.5.SummaryDifference0.7%

- Check65 days agoChange DetectedThe study record version history now shows Revision: v3.5.5, replacing the previous v3.5.4. This indicates an updated page revision in the system without altering the underlying study data.SummaryDifference0.1%

Stay in the know with updates to AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial page.